Physician profile
Arianna Bender
NPI 1609942598
$1,473.51
in general payments reported to CMS, 2019-2025
22 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $114 · 2021: $475 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $219.02 | 2019-2021 | |
| Amgen INC. | $155.21 | 2021 | |
| Allergan, INC. | $149.47 | 2019 | |
| Inspire Medical Systems, INC. | $136.18 | 2019 | |
| Glaxosmithkline, LLC. | $121.83 | 2025 | Benlysta |
| Amarin Pharma, INC. | $79.52 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.96 | 2020-2021 | |
| Radius Health, INC. | $71.19 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.95 | 2021 | |
| Lilly USA, LLC | $64.25 | 2021 | |
| Shire North American Group INC | $63.35 | 2019 | |
| Novo Nordisk INC | $63.09 | 2019 | |
| Horizon Therapeutics Plc | $33.58 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $31.95 | 2019-2021 | |
| Tactile Systems Technology INC | $25.14 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $17.95 | 2021 | |
| Eisai INC. | $17.23 | 2021 | |
| Pfizer INC. | $17.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.20 | 2020 | |
| Sanofi Pasteur INC. | $15.51 | 2019 | |
| Genzyme Corporation | $15.02 | 2021 | |
| Astellas Pharma US INC | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arianna Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.